RWM
HALO icon

Rialto Wealth Management’s Halozyme HALO Stock Holding History

Rialto Wealth Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.58K Buy
33
+19
+136% +$1.3K ﹤0.01% 1026
2026
Q1 		$905 Buy
14
+2
+17% +$141 ﹤0.01% 1150
2025
Q4 		$808 Sell
12
-67
-85% -$4.51K ﹤0.01% 1067
2025
Q3 		$5.79K Buy
79
+77
+3,850% +$5.12K ﹤0.01% 477
2025
Q2 		$105 Buy
+2
New +$114 ﹤0.01% 1524

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Rialto Wealth Management's HALO Position: Q2 2026 in Review

Rialto Wealth Management increased its Halozyme (HALO) stake by 136% in Q2 2026, buying an estimated $1.3K and bringing the position to 33 shares worth $2.58K. The position accounts for ﹤0.01% of the portfolio, ranked #1026.

Rialto Wealth Management first reported a position in HALO in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.79K in Q3 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Rialto Wealth Management held 33 shares of Halozyme worth $2.58K as of Q2 2026.
  • Rialto Wealth Management bought 19 Halozyme shares in Q2 2026, an estimated $1.3K.
  • Halozyme made up ﹤0.01% of Rialto Wealth Management's portfolio in Q2 2026, its #1026 holding.
  • Rialto Wealth Management first reported a position in Halozyme in Q2 2025 and has held it in 5 quarters since.
  • Rialto Wealth Management's Halozyme position peaked at $5.79K in Q3 2025.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.